Amgen’s stock fell 7% after an analyst posted a note on MariTide’s influence on bone density which was noticed in a data ...

Key Takeaways Amgen refutes in a press release that its trial obesity drug, MariTide, may cause bone loss density. Amgen's ...

Dear Susan, While osteoporosis is much more common in adults age 60 and older, it can strike younger people too. In fact, ...

This metabolic condition directly affects the bones by reducing its density as well as quality. "In the individuals suffering ...

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

Popular semaglutide-based drugs used for weight loss may reduce chronic and acute pain, which could make them a promising ...

The move puts Amazon in direct competition with Hims & Hers, a direct-to-consumer telehealth company that offers treatment ...

"Vergent concludes enrolment for lung cancer study of VGT-309" was originally created and published by Clinical Trials Arena, ...

From constipation to muscle loss, the side effects of some weight loss and diabetes medications can be daunting to patients.

In a move to safeguard its dominant position in cancer treatments, Merck agreed to license a drug from a Chinese company ...

“It will help in avoiding consumer protection cases of medical negligence,” said Bhushan, adding it will be easy for the ...

KNOXVILLE, Tenn. – Kalen DeBoer's message to Alabama football Saturday night after the Crimson Tide's 24-17 loss to Tennessee was simple. Look inward. Do some soul-searching. Get back to work.